Sign in
Taking peopleNo phase

Self-harm Behaviour Among the Most At-risk Adolescents

Key facts

Who runs it
University of Ljubljana, Faculty of Medicine
Where
Slovenia2 sites in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
400 people, planned
Started
23 Mar 2023
Planned end
Oct 2025
Type of study
Observational, 2 groups
Treatments tested
  • Enrollment questionnaire, General questionnaire1, General questionnaire2, General questionnaire3
  • Columbia Suicide Severity Rating Scale (CSSRS)
  • The Brief Non-Suicidal Self-Injury Assessment Tool (B-NSSI-AT)
  • Experiences in Close Relationships-Relationship Structures (ECR-RS)
  • Trauma Symptom Checklist for Children (TSCC)
  • Personality Assessment Inventory-Adolescent (PAI-A)
  • Inventory Of Statements About Self-Injury; ISAS
  • The Level of Personality Functioning Scale-Brief Form 2.0; LPFSBF 2.0
  • Borderline Personality Features Scale, BPFSC-11
  • Dynamic Appraisal of Situational Aggression-Youth Version (DASA-YV)
  • Adolescent Self-Harm Risk Scale; ASHRS
  • Lifetime Incidence of Traumatic Events questionnaire (LITE)
  • Genetic methods
Record updated
28 March 2025

Who can take part

Age
13 years to 18 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 16 criteriaShow less

Who can take part

  • Suicidality
  • Self-harming with no intention to die
  • Age 13-19

Who cannot take part

  • Confirmed acute psychotic disorder
  • Severe physical illness (e.g. cardiovascular or renal disease)
  • Disease of the central nervous system (e.g. encephalitis, brain injury or haemorrhage, epilepsy)
  • Known mental disorder (e.g. depression, bipolar disorder, schizophrenia, intellectual disability)
  • Severe physical illness (e.g. cardiovascular or renal disease)
  • Disease of the central nervous system (e.g. encephalitis, brain injury or haemorrhage, epilepsy)
  • Mental disorder, history of suicidality or self-injurious behaviour in a first-degree relative (a parent or a sibling)
  • Intellectual disability
  • Acute poisoning (including with psychoactive substances); CONTROL GROUP:
  • Suicidality
  • Self-harming with no intention to die
  • Acute poisoning (including with psychoactive substances)

Other criteria

  • CLINICAL GROUP:

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 13 and 18 years old?

This trial is currently available in Slovenia.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

In the proposed study, three objectives will be pursued:

Read full original descriptionShow less

1. To develop a method to identify more effectively the acute and long-term risk of adolescents with the most threatening self-harm behaviours. 2. To identify the factors that influence the risk of self-harm behaviours and the success of treatment/treatment of these behaviours in the most at-risk adolescents (changes in these factors). 3. Develop guidelines for more effective treatment of the most at-risk adolescents.

For this purpose, a sample of approximately 200 young people who will be hospitalised for suicide risk (the most at risk in Slovenia) and an approximately equal number of healthy adolescents will be included. At inclusion, the presence of several factors will be assessed by reviewing demographic data, clinical diagnosis, self-assessment questionnaires and clinical psychological tests (CSSRS, B-NSSI-AT, ISAS, LPFS-BF2.0, BPFSC-11, TSCC, PAI, ECR-RS, DASA-YV, ASHRS), social assessment, and blood sampling for genetic analyses (DNA isolation, sequencing, nucleotide sequence recognition, quantification and evaluation of short tandem repeats, identification of methylation sites). Longitudinal tracking of autoaggressive events and heteroaggressive events during hospitalisation will be performed and recorded on an ongoing basis. The risk and protective factors of the adolescents most at risk will be compared with a control group of adolescents. The same factors will be reassessed in the most at-risk adolescents after 6 and 18 months of treatment as usual. The data will be collected in a data entry and storage system that will ensure the privacy of the data entered in accordance with the GDPR.

This will allow the investigators to identify young people at particular risk of severe self-harm behaviour more reliably, to target them for more intensive and effective treatment, and thus to improve their safety, quality of life and prognosis in the short and long term.

The 2 groups in the trial

  • Patients

    The Enrollment Kit and Time1 Kit will be administered at enrollment, Time2 Kit will be administered before discharge and Time 3 kit after 6 and 18 months post hospitalization (see Detailed description and Study Protocol). The interventions will be Treatment as usual.

    Treatment: Enrollment questionnaire, General questionnaire1, General questionnaire2, General questionnaire3, Columbia Suicide Severity Rating Scale (CSSRS), The Brief Non-Suicidal Self-Injury Assessment Tool (B-NSSI-AT), Experiences in Close Relationships-Relationship Structures (ECR-RS), Trauma Symptom Checklist for Children (TSCC), Personality Assessment Inventory-Adolescent (PAI-A), Inventory Of Statements About Self-Injury; ISAS, The Level of Personality Functioning Scale-Brief Form 2.0; LPFSBF 2.0, Borderline Personality Features Scale, BPFSC-11, Dynamic Appraisal of Situational Aggression-Youth Version (DASA-YV), Adolescent Self-Harm Risk Scale; ASHRS, Lifetime Incidence of Traumatic Events questionnaire (LITE), and Genetic methods

  • Controls

    The Enrollment Kit and the Time Kit1 will be administered (see Detailed description and Study Protocol).

    Treatment: Enrollment questionnaire, General questionnaire1, General questionnaire2, General questionnaire3, Columbia Suicide Severity Rating Scale (CSSRS), The Brief Non-Suicidal Self-Injury Assessment Tool (B-NSSI-AT), Experiences in Close Relationships-Relationship Structures (ECR-RS), Trauma Symptom Checklist for Children (TSCC), Personality Assessment Inventory-Adolescent (PAI-A), Inventory Of Statements About Self-Injury; ISAS, The Level of Personality Functioning Scale-Brief Form 2.0; LPFSBF 2.0, Borderline Personality Features Scale, BPFSC-11, Dynamic Appraisal of Situational Aggression-Youth Version (DASA-YV), Adolescent Self-Harm Risk Scale; ASHRS, Lifetime Incidence of Traumatic Events questionnaire (LITE), and Genetic methods

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Influences on and Prevention of Self-harm Behaviour Among the Most At-risk Adolescents
Criteria questions
Built from NCT05765864, who can take part
Record updated
28 March 2025